These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 3470960

  • 1. Reaction of transcutaneous PO2 and laser Doppler flow signal on intraarterial infusion of PGE1 and nucleotide phosphates in patients with peripheral arterial occlusive disease.
    Caspary L, Creutzig A, Alexander K.
    Vasa Suppl; 1987; 17():17-22. PubMed ID: 3470960
    [No Abstract] [Full Text] [Related]

  • 2. Transcutaneous PO2 and laser Doppler flowmetry in patients with arterial occlusive disease receiving intraarterial infusions of PGE1 or nucleotide phosphates.
    Caspary L, Creutzig A, Alexander K.
    Prog Clin Biol Res; 1987; 242():433-8. PubMed ID: 2959965
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of peripheral arterial occlusive disease in stage IIb with intermittent short-term infusion of prostaglandin E1.
    Zanke BW, Hach W, Ozen Y, Sauerwein G.
    Vasa Suppl; 1987; 17():36-8. PubMed ID: 3470964
    [No Abstract] [Full Text] [Related]

  • 4. [Vital capillary microscopic examination and transcutaneous pO2-measurements by intravenous prostaglandin E1 infusion].
    Heidrich H, Lammersen T.
    Dtsch Med Wochenschr; 1985 Aug 23; 110(34):1283-5. PubMed ID: 4040847
    [Abstract] [Full Text] [Related]

  • 5. [Long term results of intraarterial infusion therapy in peripheral arterial occlusive diseases].
    Hild R, Spaan G, Stein U.
    Med Welt; 1981 Apr 03; 32(14):448-51. PubMed ID: 7219157
    [No Abstract] [Full Text] [Related]

  • 6. PGE1 in arterial occlusive disease stage III and IV.
    Bruch HP, Hörl M, Schindler G.
    Vasa Suppl; 1987 Apr 03; 17():26-31. PubMed ID: 3470962
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical experiences with prostaglandin E1 in severe peripheral artery disease].
    Carlson LA, Jogestrand T, Kaijser L, Olsson AG.
    Lakartidningen; 1977 Aug 03; 74(31):2629-33. PubMed ID: 895269
    [No Abstract] [Full Text] [Related]

  • 8. [Reflex oximetry for evaluating blood redistribution in patients with arterial occlusive disease treated with PGE1].
    Thum J, Caspary L, Creutzig A, Alexander K.
    Vasa Suppl; 1992 Aug 03; 35():39-41. PubMed ID: 1481056
    [No Abstract] [Full Text] [Related]

  • 9. [Intermittent intra-arterial infusion treatment of severe intermittent claudication--results of a prospective double-blind study of prostaglandin E1 versus energy-rich phosphates].
    Creutzig A, Caspary L, Radeke U, Specht S, Alexander K.
    Vasa Suppl; 1988 Aug 03; 23():133-5. PubMed ID: 3061036
    [No Abstract] [Full Text] [Related]

  • 10. [Intermittent intra-arterial infusion treatment of severe intermittent claudication. Results of a prospective double-blind study: prostaglandin El versus energy-rich phosphates].
    Creutzig A, Caspary L, Radeke U, Specht S, Ranke C, Alexander K.
    Med Klin (Munich); 1988 Jun 17; 83(13-14):434-8. PubMed ID: 3062344
    [No Abstract] [Full Text] [Related]

  • 11. [Transcutaneous pO2 and laser Doppler flux in increasing doses of intraarterial and intravenously administered prostaglandin E1].
    Creutzig A, Caspary L, Ranke C, Kiessling D, Wilkens J, Frölich J, Alexander K.
    Vasa; 1987 Jun 17; 16(2):114-8. PubMed ID: 2955602
    [No Abstract] [Full Text] [Related]

  • 12. [1st experiences with prostaglandin E1 long-term intra-arterial perfusion in advanced arterial occlusive disease of the lower extremities stage IV].
    Gruss JD, Kawai S, Karadedos C, Bartels D.
    Dtsch Med Wochenschr; 1978 Oct 13; 103(41):1624-5. PubMed ID: 699778
    [No Abstract] [Full Text] [Related]

  • 13. Clinical effects of intravenously administered prostaglandin E1 in patients with rest pain due to peripheral obliterative arterial disease (POAD)--a preliminary report on a placebo-controlled double-blind study.
    Diehm C, Stammler F, Hübsch-Müller C, Eckstein HH, Simini B.
    Vasa Suppl; 1987 Oct 13; 17():52-6. PubMed ID: 3551154
    [No Abstract] [Full Text] [Related]

  • 14. Effects of intra-arterial prostaglandin E1 in patients with peripheral arterial occlusive disease.
    Creutzig A, Creutzig H, Alexander K.
    Eur J Clin Invest; 1986 Dec 13; 16(6):480-5. PubMed ID: 3104047
    [Abstract] [Full Text] [Related]

  • 15. [Modification of collateral arteries by intra-arterial prostaglandin El infusion].
    Rudofsky G.
    Vasa Suppl; 1987 Dec 13; 20():215-7. PubMed ID: 3480596
    [No Abstract] [Full Text] [Related]

  • 16. Intraarterial prostaglandine E1 in arterial occlusive disease (AOD) stages III and IV.
    Herold A, Bruch HP, Hörl M, Düsel W.
    Prog Clin Biol Res; 1987 Dec 13; 242():439-44. PubMed ID: 2959966
    [Abstract] [Full Text] [Related]

  • 17. [Role and place of prolonged intra-arterial infusion in the treatment of obliterating arterial diseases of the lower extremities].
    Belichenko IA, Kungurtsev VV, Dibirov MD.
    Khirurgiia (Mosk); 1980 Mar 13; (3):48-51. PubMed ID: 7366097
    [No Abstract] [Full Text] [Related]

  • 18. Some haemorheological factors and transcutaneous PO2 in patients with a peripheral arterial occlusive disease after treatment with naftidrofuryl.
    Krupiński K, Bielawiec M, Szpak A, Płonowski A.
    Mater Med Pol; 1994 Mar 13; 26(1):17-20. PubMed ID: 7857406
    [Abstract] [Full Text] [Related]

  • 19. [Comparative effectiveness of drug preparations given by intraarterial regional infusion to patients with occlusion of the distal arterial bed].
    Silaev IuS, Avchenko MT, Gus'kov OI.
    Klin Med (Mosk); 1984 Jun 13; 62(6):89-93. PubMed ID: 6471805
    [No Abstract] [Full Text] [Related]

  • 20. Prostaglandin E1 in chronic arterial disease--a multicenter study.
    Trübestein G, Diehm C, Gruss JD, Horsch S.
    Vasa Suppl; 1987 Jun 13; 17():39-43. PubMed ID: 3470965
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.